Skip to main content

The Origins of GLP-1 Innovation

Share on:
Ozempic and similar GLP-1 drugs—with their quick weight-loss effects—have become ubiquitous topics in health care and popular culture. While this new frontier of pharmaceuticals became wildly popular in just a few years, the science took decades to develop. Much of the research and innovation have ties to Indiana University, and a key player is IU Distinguished Professor Richard DiMarchi. In this episode, DiMarchi discusses the trend of GLP-1s and his contributions to the research that made them possible.

Also find this episode on:

Host

J.D. Denny, BS’90, MA’01, is director of audience development and publishing for the IU Foundation and editor in chief of the IU Alumni Magazine.

Guests

Richard DiMarchi is a Distinguished Professor of Chemistry and Gill Chair in Biomolecular Sciences at Indiana University. DiMarchi is a member of the National Academy of Medicine and the National Inventors Hall of Fame. His research was key to the discovery and development of the GLP-1 drugs that have transformed the treatment of obesity and diabetes.

Subscribe to We Are IU